Cargando…
Retraction Note: Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: a potential therapy against pathogenic influenza virus
Autores principales: | Zhao, Jiangnan, Zhu, Meiying, Jiang, Hao, Shen, Simen, Su, Xin, Shi, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10172383/ https://www.ncbi.nlm.nih.gov/pubmed/37165053 http://dx.doi.org/10.1038/s41598-023-34694-8 |
Ejemplares similares
-
RETRACTED ARTICLE: Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: a potential therapy against pathogenic influenza virus
por: Zhao, Jiangnan, et al.
Publicado: (2019) -
Author Correction: Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: a potential therapy against pathogenic influenza virus
por: Zhao, Jiangnan, et al.
Publicado: (2020) -
Retraction Note: Serum sphingosine-1-phosphate levels and Sphingosine-1-Phosphate gene polymorphisms in acute respiratory distress syndrome: a multicenter prospective study
por: Zhao, Jiangnan, et al.
Publicado: (2022) -
Retraction Note to: IRE1α-XBP1 but not PERK inhibition exerts anti-tumor activity in osteosarcoma
por: Sasa, Keita, et al.
Publicado: (2022) -
The Role and Mechanism of S1PR5 in Colon Cancer [Retraction]
Publicado: (2021)